Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | D06AX01 |
UNII: | 59XE10C19C |
InChI Key | IECPWNUMDGFDKC-MZJAQBGESA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C31H48O6 |
Molecular Weight | 516.72 |
AlogP | 5.67 |
Hydrogen Bond Acceptor | 5.0 |
Hydrogen Bond Donor | 3.0 |
Number of Rotational Bond | 5.0 |
Polar Surface Area | 104.06 |
Molecular species | ACID |
Aromatic Rings | 0.0 |
Heavy Atoms | 37.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Elongation factor G inhibitor | PubMed |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Secreted protein
|
- | - | 12000 | - | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 40 | |
Transporter
Primary active transporter
ATP-binding cassette
ABCB subfamily
|
- | 10100-11500 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Keloid | 3 | D007627 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
Infections | 2 | D007239 | ClinicalTrials |
Skin Diseases | 2 | D012871 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 6990-06-3 |
ChEBI | 29013 |
ChEMBL | CHEMBL374975 |
DrugBank | DB02703 |
DrugCentral | 1261 |
EPA CompTox | DTXSID0023086 |
FDA SRS | 59XE10C19C |
Human Metabolome Database | HMDB0015570 |
Guide to Pharmacology | 10815 |
PDB | FUA |
PharmGKB | PA164749648 |
PubChem | 3000226 |
SureChEMBL | SCHEMBL25646 |
ZINC | ZINC000008143796 |